Sveriges mest populära poddar
Bloomberg Intelligence
NyheterNäringsliv

Bloomberg's Krutoholow on Mylan To Sell Generic EpiPen (Audio)

6 min•29 augusti 2016

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010HEALTHCARE IN FOCUS: Liz Krutoholow, Specialty Pharma and Biotech Analyst for Bloomberg Intelligence, on Mylan selling a generic version of EpiPen to quell outcry over pricing.

See omnystudio.com/listener for privacy information.

Fler avsnitt av Bloomberg Intelligence

Visa alla avsnitt av Bloomberg Intelligence
Bloomberg Money: 'Gold Has Been in Bull Market for 25 Years'
•38 min
OpenAI’s Revenue Run Rate Tops $40 Billion Ahead of IPO
•22 min
Anthropic in Talks to Buy Startup Decart for $6 Billion
•25 min
CoreWeave Shares Soar After Booming AI Demand Boosts Outlook
•26 min
Apollo Inks $2.6 Billion Financing Deal With NY Yankees
•21 min
Intel to Sell $15 Billion in Stock After AI Boosts Demand
•22 min
Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase
•43 min
Under Armour Cuts Sales View on Softer Demand Around the World
•22 min
Warner Bros. Sales Fall on Loss of NBA, Weak Film Slate
•28 min
SpaceX’s $101 Billion Unlock Heaps Pressure on Battered Shares
•27 min

Bloomberg Intelligence med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.